NLC Health Ventures
Industry Focus
Geographic Focus
NLC Health Ventures is Europe's leading healthtech venture builder and early-stage investor dedicated to bridging the gap between scientific discoveries and market-ready healthcare solutions. Founded in 2015 with a mission to bring science to life, NLC addresses the critical problem that 95% of healthtech inventions never reach patients. The organization operates at scale by finding, building, and scaling transformative health innovations from universities, academic hospitals, and corporates across Europe and beyond. NLC's unique model combines entrepreneurship at scale with a comprehensive support ecosystem, utilizing a team of 80+ healthcare and business professionals alongside a network of 2,500+ inventors, experts, and over 1,000 global specialists. The company builds 20-25 ventures annually across biotech, medtech, digital health, and green health sectors, focusing on innovations that improve prevention, diagnosis, treatment, and self-care while enhancing workforce vitality and reducing environmental impact. As a Certified B-Corp with a B Impact score of 91.5 and SFDR-9 compliant funds, NLC maintains strong commitments to ESG principles and UN Sustainable Development Goals 3, 9, and 17. The organization has built over 100 ventures since inception, with portfolio companies collectively raising over €160M and impacting 2.4 million patients. NLC's approach dramatically increases the chance of maturing healthcare innovations to market by leveraging shared learnings, resources, and captive funds across its portfolio, making early-stage healthcare investment accessible to both retail and institutional investors.
2015
15 Companies
3X Higher